Philip E. Johnston

553 total citations
23 papers, 379 citations indexed

About

Philip E. Johnston is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Emergency Medical Services. According to data from OpenAlex, Philip E. Johnston has authored 23 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Geriatrics and Gerontology and 5 papers in Emergency Medical Services. Recurrent topics in Philip E. Johnston's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Patient Safety and Medication Errors (4 papers) and Pharmaceutical studies and practices (4 papers). Philip E. Johnston is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Patient Safety and Medication Errors (4 papers) and Pharmaceutical studies and practices (4 papers). Philip E. Johnston collaborates with scholars based in United States, Canada and United Kingdom. Philip E. Johnston's co-authors include Russell L. Rothman, Lee Sanders, Charles W. Stratton, Eliana M. Perrin, Vivian I. Franco, Joanne Finkle, Leena Choi, Disha Kumar, William Schaffner and Wright C. Pinson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and The American Journal of Gastroenterology.

In The Last Decade

Philip E. Johnston

22 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philip E. Johnston United States 10 81 71 60 55 51 23 379
Gene A. Gibson United States 12 77 1.0× 86 1.2× 71 1.2× 58 1.1× 25 0.5× 22 505
Sidna M. Scheitel United States 11 116 1.4× 63 0.9× 94 1.6× 32 0.6× 31 0.6× 18 568
Catherine E. Cooke United States 16 116 1.4× 88 1.2× 150 2.5× 66 1.2× 34 0.7× 57 778
Michael P. Gulseth United States 13 67 0.8× 49 0.7× 42 0.7× 37 0.7× 45 0.9× 27 680
Syed Wasif Gillani United Arab Emirates 14 87 1.1× 134 1.9× 81 1.4× 38 0.7× 23 0.5× 97 693
Gary Tataronis United States 15 61 0.8× 50 0.7× 166 2.8× 82 1.5× 73 1.4× 24 767
Robert J. Cluxton United States 11 77 1.0× 39 0.5× 37 0.6× 58 1.1× 34 0.7× 25 459
Paul J. Godley United States 17 43 0.5× 76 1.1× 132 2.2× 82 1.5× 36 0.7× 41 605
Mark P. Okamoto United States 17 57 0.7× 133 1.9× 223 3.7× 77 1.4× 36 0.7× 28 818
Linda Awdishu United States 14 124 1.5× 73 1.0× 70 1.2× 81 1.5× 94 1.8× 57 846

Countries citing papers authored by Philip E. Johnston

Since Specialization
Citations

This map shows the geographic impact of Philip E. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Johnston more than expected).

Fields of papers citing papers by Philip E. Johnston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip E. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Johnston. The network helps show where Philip E. Johnston may publish in the future.

Co-authorship network of co-authors of Philip E. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Philip E. Johnston. A scholar is included among the top collaborators of Philip E. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip E. Johnston. Philip E. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnston, Philip E., et al.. (2025). CELT vascular closure device for larger NES arteriotomies: A single-center retrospective analysis. Interventional Neuroradiology. 4004436364–4004436364.
2.
Romaine, Sam, Jessica Potter, Aakash Khanijau, et al.. (2020). Accuracy of a Modified qSOFA Score for Predicting Critical Care Admission in Febrile Children. PEDIATRICS. 146(4). 40 indexed citations
3.
Mole, Damian J., Usha Gungabissoon, Philip E. Johnston, et al.. (2016). Identifying risk factors for progression to critical care admission and death among individuals with acute pancreatitis: a record linkage analysis of Scottish healthcare databases. BMJ Open. 6(6). e011474–e011474. 23 indexed citations
4.
Hobson, Eric H., et al.. (2015). Staging a Reflective Capstone Course to Transition PharmD Graduates to Professional Life. American Journal of Pharmaceutical Education. 79(1). 14–14. 15 indexed citations
5.
Stiles, Renée A., Stephen A. Deppen, M. Kathleen Figaro, et al.. (2007). Behind-the-Scenes of Patient-Centered Care. Medical Care. 45(12). 1205–1209. 18 indexed citations
6.
Johnston, Philip E., Daniel J. France, Daniel W. Byrne, et al.. (2006). Assessment of adverse drug events among patients in a tertiary care medical center. American Journal of Health-System Pharmacy. 63(22). 2218–2227. 13 indexed citations
7.
Johnston, Philip E., et al.. (2006). Exhuberance Over Exubera. Clinical Diabetes. 24(3). 110–114. 9 indexed citations
8.
Johnston, Philip E., et al.. (2006). The epidemiology of medication prescribing errors in the emergency department.. PubMed. 968–968. 9 indexed citations
9.
Schwarz, Ute I., Philip E. Johnston, David G. Bailey, et al.. (2005). Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. British Journal of Clinical Pharmacology. 62(4). 485–491. 24 indexed citations
10.
Johnston, Philip E., et al.. (1999). Bromfenac(Duract)-Associated Hepatic Failure Requiring Liver Transplantation. The American Journal of Gastroenterology. 94(8). 2299–2301. 40 indexed citations
12.
Branch, Robert A., et al.. (1992). The formulary: An educational tool for clinical pharmacology. Clinical Pharmacology & Therapeutics. 51(5). 481–488. 9 indexed citations
13.
Birgersdotter‐Green, Ulrika, Renata E. Bluhm, Philip E. Johnston, & Jason D. Morrow. (1992). Propafenone for Cardiac Arrhythmias. The American Journal of the Medical Sciences. 303(2). 123–128. 3 indexed citations
14.
Branch, Robert A., et al.. (1992). Lisinopril, A New Angiotensin Converting Enzyme Inhibitor. The American Journal of the Medical Sciences. 303(5). 340–344. 1 indexed citations
15.
Johnston, Philip E.. (1992). Adverse drug reaction surveillance and risk management. PubMed. 12(2). 22–23. 2 indexed citations
16.
Stratton, Charles W., et al.. (1992). Focused microbiological surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance problems. Diagnostic Microbiology and Infectious Disease. 15(2). 2–3. 36 indexed citations
17.
Robin, Deborah W., Renata E. Bluhm, Italo Biaggioni, & Philip E. Johnston. (1991). Selegiline in the Treatment of Parkinson’s Disease. The American Journal of the Medical Sciences. 302(6). 392–395. 2 indexed citations
18.
Brown, Nancy J., Philip E. Johnston, Patricia A. Arns, Renata E. Bluhm, & Robert A. Branch. (1990). Octreotide: A Long-Acting Somatostatin Analog. The American Journal of the Medical Sciences. 300(4). 267–273. 10 indexed citations
19.
Johnston, Philip E., Jason D. Morrow, & Robert A. Branch. (1990). Use of a database computer program to identify trends in reporting of adverse drug reactions. American Journal of Health-System Pharmacy. 47(6). 1321–1327. 9 indexed citations
20.
Stratton, Charles W., Lowell Anthony, Philip E. Johnston, & Robert A. Branch. (1988). Topics in Clinical Pharmacology: A Review of Ceftriaxone: A Long-Acting Cephalosporin. The American Journal of the Medical Sciences. 296(3). 221–222. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026